Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK506MR vs Prograf in Kidney Transplantation
NCT00481819Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2007
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus + Wuzhi capsule in kidney transplant rejection (2 arms), sponsored by Astellas Pharma. Primary endpoint: Event rate of patients with acute rejections at 12 weeks. Started Jul 2007; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00481819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481819.